Michael Petusky

Stock Analyst at Barrington Research

(2.22)
# 2,817
Out of 5,090 analysts
212
Total ratings
39.79%
Success rate
-2.55%
Average return

Stocks Rated by Michael Petusky

Merit Medical Systems
Nov 14, 2025
Maintains: Outperform
Price Target: $106
Current: $83.43
Upside: +27.05%
DENTSPLY SIRONA
Nov 10, 2025
Maintains: Outperform
Price Target: $18$14
Current: $11.25
Upside: +24.44%
Haemonetics
Nov 7, 2025
Maintains: Outperform
Price Target: $86$90
Current: $83.94
Upside: +7.22%
Anika Therapeutics
Nov 6, 2025
Maintains: Outperform
Price Target: $15$16
Current: $9.60
Upside: +66.67%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $78$79
Current: $73.62
Upside: +7.31%
Orthofix Medical
Nov 5, 2025
Maintains: Outperform
Price Target: $17$18
Current: $15.90
Upside: +13.21%
Option Care Health
Oct 31, 2025
Maintains: Outperform
Price Target: $38
Current: $29.89
Upside: +27.13%
OPKO Health
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.34
Upside: +67.91%
U.S. Physical Therapy
Oct 24, 2025
Maintains: Outperform
Price Target: $103
Current: $75.03
Upside: +37.28%
LeMaitre Vascular
Oct 15, 2025
Maintains: Outperform
Price Target: $95
Current: $84.53
Upside: +12.39%
Maintains: Outperform
Price Target: $1.25$1.5
Current: $0.74
Upside: +102.81%
Downgrades: Market Perform
Price Target: n/a
Current: $7.63
Upside: -